Bronchial asthma is considered an umbrella diagnosis for various diseases with certain pathophysiological mechanisms (endotypes) and variable clinical manifestations (phenotypes). The phenotype of exercise-induced asthma is one of the most common variants of the disease in children and adolescents. The treatment tactic of acute asthma attack is unified and depends of the severity in contrast to preventive therapy the vector of which provides an individualized approach. However, the issues concerning the duration, frequency of administration and amount of drugs prescription not finally resolved. The purpose of the study was to evaluate the blood immunological parameters in patients with exercise-induced asthma phenotype to predict the severity of disease exacerbation and optimize the reliever therapy. Material and methods. We examined 43 children suffering from exercise-induced asthma. Two clinical groups were formed according to the severity of the exacerbation. The first group included 22 patients with moderate exacerbation of asthma, and the second group had 21 children with severe symptoms of the disease, which was interpreted as a severe asthma attack. There were not any significant differences by sex, place of residence, age and diseases duration among comparison groups. The obtained results showed a significant increase in the level of B-lymphocytes in patients of first clinical group (26.64 %) compared with children with severe exacerbation (20.40 %), increase content of T-lymphocytes (due to T-helper cells) in schoolchildren of the second clinical group (42.32 %) compared with patients with moderate asthma attack (33.32 %). The attributive risk of more severe disease exacerbation with B-lymphocytes ≤20 % and T- helper cells ≥20 % was 36.6 %, the relative risk was 1.9 with odds ratio 5.0. A significantly higher level of pharmazan-positive neutrophils in spontaneous and stimulated modifications of the nitro blue tetrazolium test was recorded in patients with moderate exacerbation (35.18 % and 45.09 %) compared with children of the second clinical group (19.33 % and 27.81 %). The content of neutrophils in the spontaneous nitro blue tetrazolium test ≤15 % allowed evaluating severe compared with moderate asthma attack with specificity of 95.5 %, positive predictive value of 90.9 %, and positive likelihood ratio 10.5. Conclusion. The use of certain immunological parameters allows working out an individual plan for asthma attacks and may reduce the frequency of severe exacerbations in children suffering from exercise-induced bronchial asthma

Keywords: children, bronchial asthma, exacerbation, prediction

Full text: PDF (Ukr) 284K

1. Kuruvilla ME, Lee FE, Lee GB. Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease. Clin Rev Allergy Immunol. 2019; 56(2): 219-33. https://doi.org/10.1007/s12016-018-8712-1
2. Dong Z, Xiong L, Zhang W, Gibson PG, Wang T, Lu Y, et al. Holding the inflammatory system in check: TLRs and their targeted therapy in asthma. Med Inflamm. 2016; 2016: Article ID 2180417, 8 pages. https://doi.org/http://dx.doi.org/10.1155/2016/2180417
3. Brussino L, Heffler E, Bucca C, Nicola S, Rolla G. Eosinophils Target Therapy for Severe Asthma: Critical Points. Biomed Res Int. 2018 Oct 25; 2018: 7582057. https://doi.org/10.1155/2018/7582057
4. Gao H, Ying S, Dai Y. Pathological Roles of Neutrophil-Mediated Inflammation in Asthma and Its Potential for Therapy as a Target. J Immunol Res. 2017; 2017: 3743048. https://doi.org/10.1155/2017/3743048
5. Kruse RL, Vanijcharoenkarn K. Drug repurposing to treat asthma and allergic disorders: Progress and prospects. Allergy. 2018 Feb; 73(2): 313-22. https://doi.org/10.1111/all.13305
6. Lin LL, Huang SJ, Ou LS, Yao TC, Tsao KC, Yeh KW, Huang JL. Exercise-induced bronchoconstriction in children with asthma: An observational cohort study. J Microbiol Immunol Infect. 2019 Jun; 52(3): 471-9. https://doi.org/10.1016/j.jmii.2017.08.013
7. Bonini M, Palange P. Exercise-induced bronchoconstriction: new evidence in pathogenesis, diagnosis and treatment. Asthma Res and Pract. 2015 Jul; 1: 2. https://doi.org/10.1186/s40733-015-0004-4
8. David MMC, Gomes ELFD, Mello MC, Costa D. Noninvasive ventilation and respiratory physical therapy reduce exercise-induced bronchospasm and pulmonary inflammation in children with asthma: randomized clinical trial. Ther Adv Respir Dis. 2018 Jan-Dec; 12: 1753466618777723. https://doi.org/10.1177/1753466618777723
9. Aggarwal B, Mulgirigama A, Berend N. Exercise-induced bronchoconstriction: prevalence, pathophysiology, patient impact, diagnosis and management. NPJ Prim Care Respir Med. 2018; 8(1): 31. https://doi.org/10.1038/s41533-018-0098-2
10. Caggiano S, Cutrera R, Di Marco A, Turchetta A. Exercise-Induced Bronchospasm and Allergy. Front Pediatr. 2017 Jun 8; 5: 131. https://doi.org/10.3389/fped.2017.0013
11. Alharbi E, Abdullah M. Asthma Attack Prediction based on Weather Factors. Periodicals of Engineering and Natural Sciences. 2019; 7(1): 408-19. https://doi.org/10.21533/pen.v7i1.422
12. Indinnimeo L, Chiappini E, Miraglia Del Giudice M; Italian Panel for the management of acute asthma attack in children Roberto Bernardini. Guideline on management of the acute asthma attack in children by Italian Society of Pediatrics. Ital J Pediatr. 2018 Apr 6; 44(1): 46. https://doi.org/10.1186/s13052-018-0481-1
13. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma. 2020. [Internet]. Available from: https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-final-_wms.pdf
14. Gupta A, Bhat G, Pianosi P. What is New in the Management of Childhood Asthma? Indian J Pediatr. 2018 Sep; 85(9): 773-81. https://doi.org/10.1007/s12098-018-2705-1
15. Bezrukov LA, Nechitaylo YuN, Cherevko SA, Mozolevskiy AF. Diagnostika i lechenie ostrykh pnevmoniy i ORVI, oslozhnennykh BOS u detey rannego vozrasta [Diagnostic and treatment of acute pneumonia and ARVI complicated by BOS in younger children]. Chernovtsy; 1989. 23 p. [Russian]
16. Lapovets LYe, Lutsyk BD. Posibnyk z laboratornoyi imunologiyi [Manual of laboratory immunology]. Lviv; 2002. 173 p. [Ukrainian]
17. Fletcher R, Fletcher S, Vagner E, Bashchinskiy SE. Klinicheskaya epidemiologiya. Osnovy dokazatel'noy meditsiny [Clinical epidemiology. Basics of Evidence-Based Medicine]. M: Media Sfera; 2004. 352 p. [Russian]
18. Xia F, Deng C, Jiang Y, Qu Y, Deng J, Cai Z, et al. IL4 (interleukin 4) induces autophagy in B cells leading to exacerbated asthma. Autophagy. 2018; 14(3) : 450-64. https://doi.org/10.1080/15548627.2017.1421884
19. Tiotiu A. Biomarkers in asthma: state of the art. Asthma Res Pract. 2018 Dec 21; 4: 10. https://doi.org/10.1186/s40733-018-0047-4
20. Johansson MW. Eosinophil Activation Status in Separate Compartments and Association with Asthma. Front Med (Lausanne). 2017; 4: 75. https://doi.org/10.3389/fmed.2017.00075
21. Rodrigo-Muñoz JM, Cañas JA, Sastre B, Rego N, Greif G, Rial M, et al. Asthma diagnosis using integrated analysis of eosinophil microRNAs. Allergy. 2019 Mar; 74(3): 507-17. https://doi.org/10.1111/all.13570
22. Kim N, Thatcher TH, Sime PJ, Phipps RP. Corticosteroids inhibit anti-IgE activities of specialized proresolving mediators on B cells from asthma patients. JCI Insight. 2017; 2(3): e88588. https://doi.org/10.1172/jci.insight.88588
23. McKeever T, Mortimer K, Wilson A, Walker S, Brightling C, Skeggs A, et al Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations. N Engl J Med. 2018 Mar 8; 378(10): 902-10. https://doi.org/10.1056/NEJMoa1714257
24. Özdemir A, Doğruel D. Efficacy of Magnesium Sulfate Treatment in Children with Acute Asthma. Med Princ Pract. 2020; 29(3): 292-8. https://doi.org/10.1159/000506595